It was first characterized by Predrag Sikiric and colleagues at the University of Zagreb in the early 1990s, and a 2025 literature and patent review cataloged its effects across gastrointestinal, musculoskeletal, and neural models
High blood pressure increases the risk of heart diseases and leads to complications such as stroke or kidney failure
Animal models of epilepsy: use and limitations
What if you or your child was able to correct the nutrient deficiency and not need the stimulant medication anymore
Synthagen Laboratories NL-GHK-Cu in the prevention of common diseases such as, among others, arteriosclerosis, cataract, diabetes, nephropathy, and Alzheimers disease The therapy with the NL-GHK-Cu peptide, thanks to its antioxidant action, allows for the inhibition and prevention of many pathological phenomena related to the eye, neurodegenerative diseases, kidney diseases, and ailments of the cardiovascular system